Balance Sheet for Adaptimmune Therapeutics plc (ADAP)

$ 9.79   -0.20 (-2.00%) Volume: 696.39k 4:00 PM EDT 2-Jul-2020
After Hours:  $ 9.40   -0.39 (-3.98%) Volume: 8.7k 5:59 PM EDT 2-Jul-2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 50,412 68,379 84,043 158,779 194,263
Restrictable Cash - - - - -
Marketable Securities 39,130 136,755 124,218 22,694 54,620
Accounts Receivable - 192 206 1,480 744
Loans Receivable - - - - -
Other Receivables - - - - 2,985
Receivables 20,671 18,156 11,660 7,727 744
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other 1,459 1,087 3,760 1,192 102
Inventories, Adjustments & Allowances - - - - -
Inventories 1,459 1,087 3,760 1,192 102
Prepaid Expenses 8,395 6,279 6,120 7,383 5,802
Current Deferred Income Taxes - - - - -
Other Current Assets 422 439 382 976 13,420
Total Current Assets 120,489 231,095 230,183 198,751 263,047
Land and Improvements - - - - -
Buildings and Improvement 27,320 26,873 27,441 4,498 1,631
Machinery, Furniture and Equipment 27,397 25,043 22,309 13,592 12,456
Construction in Progress - 126 393 14,332 1,147
Fixed Assets, Other 20,789 - - - -
Fixed Assets, Total 75,506 52,042 50,143 32,422 15,234
Gross Fixed Assets 75,506 52,042 50,143 32,422 15,234
Accumulated Depreciation (23,649) (15,924) (9,464) (4,523) (2,009)
Net Fixed Assets 51,857 36,118 40,679 27,899 13,225
Intangibles 2,198 1,473 1,337 1,268 305
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 6,999 8,050 8,948 6,597 9,244
Total Non-Current Assets 61,054 45,641 50,964 35,764 22,774
Total Assets 181,543 276,736 281,147 234,515 285,821
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 6,357 4,083 8,378 11,350 10,632
Short Term Debt 2,493 - - - -
Notes Payable - - - - -
Accrued Expenses 23,363 20,354 21,460 15,514 4,026
Accrued Liabilities 23,363 20,354 21,460 15,514 4,026
Deferred Revenues 2,128 - 38,735 11,392 12,487
Current Deferred Income Taxes - - - - -
Other Current Liabilities - - 5,741 2,014 744
Total Current Liabilities 34,341 24,437 74,314 40,270 27,889
Long Term Debt N/A N/A N/A - -
Deferred Income Tax - - - 24,962 22,939
Other Non-Current Liabilities 598 5,414 3,849 28,103 22,939
Minority Interest - - - - -
Capital Lease Obligations 22,966 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 23,564 5,414 3,849 28,103 22,939
Total Liabilities 57,905 29,851 78,163 68,373 50,828
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 123,638 246,885 202,984 166,142 234,993
Common Par 943 939 854 683 682
Additional Paid in Capital 585,623 574,208 455,401 341,200 332,363
Cumulative Translation Adjustments - - - - 172
Retained Earnings (455,664) (318,499) (231,630) (161,492) (89,913)
Treasury Stock - - - - -
Other Equity Adjustments (7,264) (9,763) (21,641) (14,249) (8,139)
Total Capitalization 123,638 246,885 202,984 166,142 234,993
Total Equity 123,638 246,885 202,984 166,142 234,993
Total Liabilities & Shareholder's Equity 181,543 276,736 281,147 234,515 285,821
Cash Flow (137,165) (95,854) (70,138) (71,579) (54,935)
Working Capital 86,148 206,658 155,869 158,481 235,158
Free Cash Flow (115,581) (109,096) (79,327) (60,953) (27,900)
Invested Capital 123,638 246,885 202,984 166,142 234,993
Shares Outstanding - Common Class Only 105,167 104,576 93,687 70,796 70,785
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 631,004 627,454 562,119 424,775 435,962
Total Common Shares Outstanding 105,167 104,576 93,687 70,796 70,785
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 104,968 97,390 87,940 70,786 70,785
Diluted Weighted Shares Outstanding 104,968 97,390 87,940 70,786 70,785